Photo from wikipedia
The use of stereotactic ablative radiotherapy (SABR) with the intention to cure stage I non-small cell lung cancer (NSCLC) in preference to surgical resection is currently a contentious and hotly… Click to show full abstract
The use of stereotactic ablative radiotherapy (SABR) with the intention to cure stage I non-small cell lung cancer (NSCLC) in preference to surgical resection is currently a contentious and hotly debated topic. It may even be claimed that SABR could impact the future management of lung cancer in the same way that percutaneous coronary stents impacted the management of ischemic heart disease.
Keywords:
management;
ablative radiotherapy;
lung cancer;
stereotactic ablative;
lung
Journal Title: Journal of thoracic disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of thoracic disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!